DBV Technologies (DBVT) Gross Profit (2020 - 2026)
DBV Technologies (DBVT) reported Gross Profit of -$3.9 million for Q1 2026, down 880.0% year-over-year from $500000.0 in Q1 2025, and down 442.42% quarter-over-quarter from -$719000.0 in Q4 2025.
DBV Technologies (DBVT) Gross Profit (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Gross Profit data on file, last reported at -$3.9 million in Q1 2026.
- Gross Profit for Q1 2026 came in at -$3.9 million, down 880.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 247.21% YoY), and the FY2025 annual result was $2.4 million, up 61.8% from the prior year.
- Gross Profit retreated to -$3.9 million in Q1 2026 per DBVT's latest filing, from -$719000.0 in the prior quarter.
- Over five years, Gross Profit peaked at $8.0 million in Q4 2023 and troughed at -$3.9 million in Q1 2026.
- A 5-year average of $973058.8 and a median of $649000.0 in 2024 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2023 and 2026: Gross Profit surged 742.46% in 2023, then sank 880.0% in 2026.
- A 5-year view of Gross Profit shows it stood at -$1.3 million in 2022, then surged by 742.46% to $8.0 million in 2023, then plunged by 98.57% to $115000.0 in 2024, then sank by 725.22% to -$719000.0 in 2025, then tumbled by 442.42% to -$3.9 million in 2026.
- Business Quant data shows DBVT's Gross Profit at -$3.9 million in Q1 2026, -$719000.0 in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.90 Mn |
| Mar 31, 2026 | -3.90 Mn |
| Dec 31, 2025 | -719,000.00 |
| Dec 31, 2025 | -719,000.00 |
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 553,000.00 |
| Sep 30, 2024 | 553,000.00 |
| Jun 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 175,000.00 |
| Mar 31, 2024 | 649,000.00 |
| Mar 31, 2024 | 649,000.00 |
| Dec 31, 2023 | 8.05 Mn |
| Dec 31, 2023 | 8.05 Mn |